series-c-plus
Stage
1
Investors
About
Valneva is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines targeting infectious diseases with significant unmet medical needs.
Explore Valneva's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.